泪道探针留置术对先天性复杂性鼻泪管阻塞治疗的临床评价

摘要

目的 评价泪道探针留置术在先天性复杂性鼻泪管阻塞治疗中的临床价值.方法 对276例(295只眼)出生1～12个月先天性复杂性鼻泪管阻塞患儿采用泪道探针留置术进行治疗,观察不同年龄组、不同阻塞性质的一次性治愈率以及不同次数探针留置术的治愈率.结果 本研究中295只眼接受泪道探针留置术进行治疗,一次性治愈259只眼,其一次性治愈率为87.7％,其中≤3个月组的一次性治愈率为95％,比～6个月组87.5％和≤12个月组74.2％高(P＜0.05),而鼻泪管膜性阻塞的治愈率比鼻泪管骨性阻塞的治愈率高(P＜0.05)；并且,不同次数泪道探针留置术之间的治愈率亦有着显著性差异(P ＜0.05).结论 泪道探针留置术对先天性复杂性鼻泪管阻塞的治疗有着较好的疗效而且宜早期采用；并且该方法也可以作为基层医院治疗先天性复杂性鼻泪管阻塞一种较好的治疗方法.%Objective To evaluate the effect of probe implantation in treatment for complex congenital nasolacriral duct obstruction.Methods Total 276 cases (295 eyes) of congenital complex nasolacrimal duct obstruction were treated with duct probe implantation within the first 12 months of birth.Cure rate were studied for different age groups and different pathologic types.Results The overall cure rate was 87.7％ (259 eyes) with single treatment.The cure rate was 95％ in infants received the treatment before 3 months of age,87.5％ in infants received the treatment between 3 months and 6 months,and 74.2％ in infants received the treatment between 6 months and 12 months.The difference in cure rate among those groups was significant (P ＜ 0.05).The cure rate was higher in patients with membranous obsstrction than in patients with bony obstruction (P ＜0.05).Conclusion Probe implantation is an effective treatment for complex congenital nasolacrimal duct obstruction.Patients should be treated early to achieve a higher cure rate.